Financial News · Live Terminal

Page 273 of 299

National Bank Financial Downgrades Newmont to Sector Perform From Outperform, Adjusts PT to $130 From $140

Newmont (NEM) has an average rating of overweight and mean price target of $143.40, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$NEM

Research68d ago

Mizuho Downgrades NXP Semiconductors to Underperform From Outperform, Adjusts PT to $188 From $255

NXP Semiconductors NV (NXPI) has an average rating of overweight and mean price target of $259.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$NXPI

Research68d ago

Baird Downgrades Albemarle to Neutral From Outperform, Price Target is $210

Albemarle (ALB) has an average rating of overweight and mean price target of $196.38, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ALB

Research68d ago

JPMorgan Downgrades NetApp to Neutral From Overweight, Adjusts PT to $110 From $125

NetApp (NTAP) has an average rating of hold and mean price target of $116.36, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$NTAP

Research68d ago

JPMorgan Downgrades Clorox to Underweight From Neutral, Adjusts Price Target to $99 From $117

Clorox (CLX) has an average rating of hold and mean price target of $116.06, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CLX

Research68d ago

Daiwa Securities Downgrades EcoproBM to Sell From Underperform; Price Target is KRW130,000

Ecopro BM (KOSDAQ:247540) has an average rating of hold and mean price target of 164,886.36 won, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

KOSDAQ:247540

Research68d ago

HSBC Upgrades Pacific Basin Shipping to Hold from Reduce; Price Target is HK$3.20

Pacific Basin Shipping (HKG:2343) has an average rating of overweight and mean price target of HK$3.48, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

HKG:2343

Research68d ago

Phillip Securities Downgrades Geely Automobile to Accumulate from Buy; Price Target is HK$26.60

Geely Automobile (HKG:0175) has an average rating of buy and mean price target of HK$27.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

HKG:0175

Research68d ago

RHB Starts Info-Tech Systems at Buy with SG$1.40 Price Target

SGX:ITS

Research68d ago

Research Alert: CFRA Keeps Hold Opinion On Adss Of Wipro Limited

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our Hold rating with a higher 12-month target price of USD2.40 (up from USD2.30), by rolling forward our valuation to FY 28 EPADS (Mar.), applying a P/E of 15.3x, which remains at a discount to its five-year average of 21.1x. The lower multiple reflects uncertainty in revenue recovery, delays in large deal ramp-ups, and slower growth as AI-related projects take longer to implement. As FY 26 results were within expectations, we maintain our FY 27 revenue forecast at INR961B and introduce our FY 28 revenue forecast of INR1,019B, implying gradual improvement as execution becomes more stable. We maintain our FY 27 EPADS forecast at INR13.33 and introduce our FY 28 EPADS forecast of INR14.82, reflecting stable margins despite modest revenue growth. We remain cautious on near-term growth due to limited visibility on demand recovery and slower revenue conversion. We believe earnings will improve only when deal ramp-ups become more consistent and client spending picks up.

$WIT

Research68d ago

Jefferies Downgrades Lingyi iTech (Guangdong) to Hold From Buy, Adjusts Price Target to 15 Yuan from 16 Yuan

SHE:002600

Research68d ago

Jefferies Upgrades JCR Pharmaceuticals to Buy From Hold, Adjusts Price Target to 900 Yen from 750 Yen

JCR Pharmaceuticals (TYO:4552) has an average rating of hold and mean price target of 711.43 yen, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

TYO:4552

Research68d ago

Research Alert: Ericsson: Q1 2026 Core Earnings Meet Consensus, Margins Under Pressure

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Ericsson's Q1 2026 core net income of SEK4.7B (-54% Q/Q, +12% Y/Y) was seasonally in line with consensus, while revenue declined to SEK49.3B (-29% Q/Q, -10% Y/Y) due to currency headwinds and lower North American network spending. Improving organic demand across all segments reflects continued 5G deployments and geographic diversification, supported by growth in the Networks, Cloud Software and Services, and Enterprise segments. Management expects the RAN market to remain flattish in 2026, with Q2 growth aligned with historical seasonality. Networks' adjusted EBITA margin declined to 19.3% from 21.0% due to higher semiconductor costs and supply chain pressures, while Cloud Software improved to 5.3% from 1.2% on better efficiency and product mix. Enterprise continues to weigh on profitability with a -34.6% EBITA margin. We believe gradual earnings progression is expected in 2H 2026 as cost discipline and efficiency measures support margin recovery despite ongoing input cost pressures.

$ERIC

Research68d ago

Research Alert: CFRA Maintains Strong Buy View On Shares Of Carpenter Technology Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our target price by $114 to $501, based on an EV/EBITDA of 19.0x our FY 28 (Jun.) EBITDA estimate, above CRS's TTM avg. fwd EV/EBITDA of 18.2x but a discount to peers' avg. fwd EV/EBITDA of 21.6x. We lift our FY 26 EPS estimate by $0.11 to $10.57 and FY 27 by $0.46 to $13.22. We initiate our FY 28 EPS forecast at $16.52. With only three qualified global suppliers of premium nickel-based superalloys, CRS enjoys exceptional pricing power, evidenced by recent long-term agreements with 30%+ price increases. The company delivered its 16th consecutive quarter of margin expansion in Q2 FY 26, with SAO margins at a record 33.1%. Management's raised FY 26 operating income guidance of $680M-$700M represents 30%-33% growth over record FY 25, while the FY 27 target of $765M-$800M remains intact, with management signaling focus on exceeding these levels. The $400M brownfield expansion adds only modest capacity relative to surging aerospace build rates targeting 2,100+ aircraft annually, 30% above pre-Covid peaks.

$CRS

Research68d ago

Research Alert: CFRA Keeps Buy Opinion On Adss Of Taiwan Semiconductor Manufacturing Company

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price to USD413 (from USD388), based on a 2026 P/E of 25.9x. The multiple represents two standard deviations above the 10-year mean of 18x, reflecting sustained margin strength, strong earnings visibility, and continued demand for leading-edge technologies. We maintain our 2026 and 2027 revenue forecasts as Q1 2026 results were in line with expectations, while Q2 guidance supports continued sequential growth and reinforces near-term visibility. All in, we raise our 2026 EPADS estimate to TWD503.96 (from TWD477.10) and 2027 EPADS to TWD755.94 (from TWD682.25), reflecting improved margin assumptions following Q1 2026 margin strength and management guidance indicating sustained profitability. Demand remains above supply, supporting utilization and pricing, although growth is paced by capacity expansion. Continued strength in advanced nodes and sustained customer demand provide visibility into earnings growth over the medium term.

$TSM

Research68d ago

Research Alert: CFRA Keeps Hold Opinion On Adss Of Xpeng Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our target price to USD20 from USD22, implying a 2026 P/S of 1.3x, a 57% discount to global EV peers' 3.0x average, reflecting margin pressure from AI investments and its second-tier market position. We lower 2026 EPADS to CNY0.33 from CNY0.86 and introduce 2027 EPADS at CNY1.00. We project revenue growth moderating to 20.5%-21% p.a. for 2026 and 2027, largely due to increased vehicle deliveries and new model launches, but declining average selling prices from intensifying competition (BYD, Geely), product mix dilution, and lower subsidies will pressure growth. Improved operating leverage and scale efficiency should support our projected modest margin improvement, but rising cost inflation and elevated R&D investment in AI will limit margin expansion potential. While Q4 2025 achieved record 21.3% gross margin and first quarterly profit, we remain cautious on sustaining profitability through 2026 given fragile margins amid an investment upcycle and intensifying EV competition in China.

$XPEV

Research68d ago

Research Alert: CFRA Maintains Buy Rating On Shares Of Dell Technologies Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target from $166 to $239, 16x our FY 28 (Jan.) EPS view, above DELL's three-year average (~11x) on AI upside. We raise our FY 27 EPS view by $0.31 to $12.80 and FY 28's by $0.49 to $14.91. Global AI data center spending continues to strengthen, and we expect DELL will continue capitalizing on this momentum as it builds its reputation in the AI server space. We also think server peer SMCI's recent export control issues could see some of its non-hyperscaler business shift toward DELL, providing upside to recent guidance, while recent takeover rumors (despite being denied by NVDA) highlight DELL's value as a critical infrastructure provider and provide further support for an above-historical multiple. The ongoing memory shortage remains a key risk, but with supply fully secured to support FY 27 guidance, we doubt a significant hit to the company's near-term margin outlook. We expect its relationship with memory makers will allow for favorable supply allocation vs. peers next year as well.

$DELL

Research68d ago

Research Alert: Vale S.a. Posts Strong Q1 2026 Operating Results

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Vale posted solid Q1 2026 (operating) results, with iron ore production of 69.7Mt (+3.0% Y/Y) and energy transition metals delivering double-digit growth, including copper at 102.3kt (+12.5% Y/Y) and nickel at 49.3kt (+12.3% Y/Y). The performance marked multiyear highs across core assets, with S11D achieving another record and Southeastern System surging 19.2% driven by Capanema's ramp-up. We view the operational momentum as validation of Vale's capital strategy and positioning for long-term value creation in energy transition metals. Management maintained 2026 guidance, expecting upper end of 335Mt-345Mt iron ore targets as Capanema reaches full capacity. Copper realizations surged 47.8% Y/Y to $13,143/t while iron ore premiums expanded 29.2%, demonstrating portfolio optimization benefits. We believe base metals are becoming increasingly important value drivers as Novo Carajas advances, though key watch items include project execution and iron ore premium sustainability.

$VALE

Research68d ago

Research Alert: CFRA Keeps Buy Opinion On Shares Of Albertsons Companies, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target at $21, based on 8.8x our FY 27 (Feb.) EPS of $2.38 (raised from $2.36; FY 28 initiated at $2.64). This multiple is near its long-term mean of 9.1x but remains a discount to its closest publicly-traded peer Kroger (~13x). Pharmacy headwinds from the Inflation Reduction Act are weighing on identical sales this fiscal year, though they are benefiting margins through a mix shift toward higher-margin generics. Margins should also improve with better digital profitability, easing GLP-1 pressure, and ongoing productivity initiatives. We expect identical sales growth to remain pressured in May-Q due to egg deflation, with both growth and profitability improving in subsequent quarters. We also believe ACI's investments in value, including lower prices and targeted promotions, should begin to drive an improvement in core grocery trends as the year progresses. Our Buy view reflects double-digit total shareholder return potential, including share repurchases and a ~4% dividend yield.

$ACI

Research68d ago

Research Alert: CFRA Maintains Sell Opinion On Shares Of J.b. Hunt Transport Services, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target by $5 to $175, using a forward P/E of 20.4x our 2027 EPS estimate of $8.57, broadly in line with historical averages. We raise our 2026 EPS estimate by $0.33 to $7.26 and 2027's by $0.48 to $8.57. We project revenues of $12.9B in 2026 and $13.7B in 2027. While JBHT delivered a solid quarter, with 5% revenue growth and strong 27% EPS growth, we remain doubtful about the company's ability to sustain margin expansion despite aggressive cost-cutting measures. We anticipate several headwinds in 2026, including rising wages due to an ongoing driver shortage, declining driver supply due to new regulatory requirements, and higher insurance costs. We believe the stock is currently overvalued at a forward P/E of 29.9x, which is near its decade high and 33% above its 10-year historical average. This premium is unjustified given the challenges ahead. Despite JBHT increasing its dividend for 22 straight years, shares yield just 0.8%.

$JBHT

Showing 5441-5460 of 5966